16th-May-2013 10:33Source: BSE

Lupin- Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Vijaykumar A Kothiwale has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992

15th-May-2013 20:55Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company in their meeting held on May 13, 2013 has g...

15th-May-2013 18:02Source: BSE

Dr Reddys Labs- Grant of Stock Options

Dr Reddys Laboratories Ltd has informed BSE that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company in their meeting held on May 13, 2013 has granted 261,650 ...

15th-May-2013 17:13Source: BSE

Cipla- Updates on Acquisition

With reference to the earlier announcement dated February 28, 2013, whereby the shareholders of the Company were advised of Cipla''s firm intention to make a cash offer (the "Offer"), to acquire (eith...

15th-May-2013 17:12Source: BSE

Lupin- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Lupin Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

15th-May-2013 16:07Source: NSE

Cipla Limited

Cipla Limited has informed the Exchange, vide letter dated May 15, 2013 regarding an update on acquisition of Cipla Medro South Africa Limited.

14th-May-2013 15:45Source: BSE

Lupin- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Girijpal Singh has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

14th-May-2013 15:02Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2013 as follows: Net Sales of Rs. 216090 lacs for the quarter ending on 31-M...

14th-May-2013 14:11Source: BSE

Dr Reddys Labs- Board recommends Final Dividend

Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2013, inter alia, has recommended a final dividend of Rs. 15/- (300%) per equity s...

13th-May-2013 19:17Source: BSE

Lupin- Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Kaushik Samanta has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992